NEOGENOMICS INC (NEO) Insider Trading Disclosures
NEOGENOMICS INC (NEO) is a publicly traded company on the Nasdaq, categorized under SIC 8734 (Services-Testing Laboratories). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: NEO
CIK: 1077183
Exchange: Nasdaq
SIC 8734: Services-Testing Laboratories
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2019 12:00:00 AM
Lead Engagement PartnerElijah Rinn
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0001628280-26-064959 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-10-05 | 8-K | 0001077183-26-000069 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | FORM 4 | 0001628280-26-060499 | View SEC Doc Filr Page |
| 4 | 2026-08-25 | 2026-08-21 | FORM 4 | 0001628280-26-058913 | View SEC Doc Filr Page |
| S-8 | 2026-08-25 | — | S-8 | 0001077183-26-000064 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001999371-26-018013 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-07 | 8-K | 0001628280-26-055697 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | FORM 4 | 0001646370-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-08-04 | — | 144 Filing | 0001950047-26-007613 | View SEC Doc Filr Page |
| 144 | 2026-07-30 | — | 144 Filing | 0001950047-26-007427 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-30 | — | SCHEDULE 13G/A Filing | 0002012383-26-003193 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0001445546-26-005565 | View SEC Doc Filr Page |
| 10-Q | 2026-07-28 | 2026-06-30 | 10-Q | 0001077183-26-000059 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-28 | 8-K | 0001077183-26-000058 | View SEC Doc Filr Page |
| 8-K/A | 2026-07-22 | 2026-07-20 | 8-K/A | 0001077183-26-000049 | View SEC Doc Filr Page |
| 8-K | 2026-07-20 | 2026-07-20 | 8-K | 0001077183-26-000045 | View SEC Doc Filr Page |
| 4 | 2026-06-25 | 2026-06-23 | FORM 4 | 0001628280-26-045501 | View SEC Doc Filr Page |
| 3 | 2026-06-25 | 2026-06-23 | FORM 3 | 0001628280-26-045499 | View SEC Doc Filr Page |
| 8-K | 2026-06-25 | 2026-06-23 | 8-K | 0001628280-26-045350 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-16 | 8-K | 0001077183-26-000037 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0001628280-26-043875 | View SEC Doc Filr Page |
| 8-K | 2026-06-17 | 2026-06-17 | 8-K | 0001077183-26-000031 | View SEC Doc Filr Page |
| 8-K | 2026-06-15 | 2026-06-15 | 8-K | 0001077183-26-000029 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001950047-26-006094 | View SEC Doc Filr Page |
| 4 | 2026-06-11 | 2026-06-09 | FORM 4 | 0001628280-26-042506 | View SEC Doc Filr Page |